In the evolving medical device and health care landscapes, investments in new technology must consider both today’s needs and tomorrow’s challenges and opportunities. A recently published article in Radiology Today provides an insight into the evaluation of SRS technologies by a multi-disciplinary team with diverse perspectives at the Mary Bird Perkins-Our Lady of the Lake Cancer Center, Louisiana, that led to them investing in a Gamma Knife ICON.

The article decribes the holistic evaluation undertaken which identified advantages of the Gamma Knife particularly in the context of the shift from using whole-brain radiotherapy (WBRT) to treating individual brain metastases with Gamma Knife Radiosurgery. The article reflects on the success of the investment with the increased confidence in treating complex brain lesions that comes with the advanced technology and dedicated intracranial design enabling the cancer centre to treat more patients with multiple brain metastases, which has increased patient volumes. The increased workflow efficiencies have helped reduce treatment wait times, enhance staff productivity, and allow care providers to spend more time with patients and less time coordinating care. Physicians are excited that the system gives them new ways to treat complex cases, including using multiple fractions over a few treatment sessions to treat larger tumours, reducing treatment times compared with WBRT, and avoiding the toxicities and cognitive declines that are associated with WBRT. Patients have benefitted from having SRS available as an alternative to invasive brain surgery, when appropriate, and have achieved successful clinical outcomes following treatment, even when other therapeutic approaches have failed. Patients also appreciate that SRS allows them to return to work and daily activities immediately following treatment with much shorter recovery times compared with invasive approaches and WBRT.

Click here to access the article